G856-1326 Screening compound: 2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

G856-1326 Screening compound: 2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one
G856-1326 Screening compound: 2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G856-1326
2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G856-1326

Molecular Formula

C26H18F3N3O2S (C26 H18 F3 N3 O2 S)

Compound Name

2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H,4H,5H-pyrimido[5,4-b]indol-4-one

IUPAC name

2-{[(2E)-3-phenylprop-2-en-1-yl]sulfanyl}-3-[4-(trifluoromethoxy)phenyl]-3H4H5H-pyrimido[54-b]indol-4-one

SMILES

O=C1N(c(cc2)ccc2OC(F)(F)F)C(SC/C=C/c2ccccc2)=Nc2c1[nH]c1c2cccc1

InChI

InChI=1S/C26H18F3N3O2S/c27-26(28,29)34-19-14-12-18(13-15-19)32-24(33)23-22(20-10-4-5-11-21(20)30-23)31-25(32)35-16-6-9-17-7-2-1-3-8-17/h1-15,30H,16H2

InChI Key

DDXJYPRFMGKVFS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05951338

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.51

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.620

Distribution Coefficient, logD

6.620

Water Solubility, LogSw

-6.28

Polar Surface Area

39.054

Acid Dissociation Constant (pKa)

14.53

Base Dissociation Constant (pKb)

0.25

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.70

G856-1326 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with G856-1326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G856-1326?
Check Price and Availability of G856-1326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G856-1326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G856-1326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G856-1326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G856-1326 available by request